Edward Tabor
- Hepatology top 0.2%
- Hepatitis C virus research 50
- Hepatitis Viruses Studies and Epidemiology 33
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Epidemiology top 0.5%
- Hepatitis B Virus Studies 87
- Liver Disease Diagnosis and Treatment 34
- Infectious Diseases top 2%
- Animal Science and Zoology top 5%
- Animal Virus Infections Studies 7
- Virology top 5%
-
- Cancer-related Molecular Pathways 14
-
- Immunotherapy and Immune Responses 8
- Co-authors
- Robert J. GeretyChu Chieh HsiaR. J. GeretyRobert H. PurcellRichard E. SamplinerL. A. SmallwoodYutaka NakashimaMilton April
- Journals
- Journal of Medical Virology (28 papers)Transfusion (12 papers)The Journal of Infectious Diseases (11 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Edward Tabor
145 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 123
- Hepatology 2.5k
- Epidemiology 2.7k
- Infectious Diseases 637
- Animal Science and Zoology 190
- Virology 88
Countries citing papers authored by Edward Tabor
This map shows the geographic impact of Edward Tabor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Tabor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Tabor more than expected).
Fields of papers citing papers by Edward Tabor
This network shows the impact of papers produced by Edward Tabor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Tabor. The network helps show where Edward Tabor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward Tabor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 4 | |
| 2 | 2019 | 2 | |
| 3 | 2015 | 3 | |
| 4 | 2005 | 2 | |
| 5 | 2003 | 208 | |
| 6 | Viruses and liver cancer | 2002 | 15 |
| 7 | 2002 | 40 | |
| 8 | 2002 | 39 | |
| 9 | 1999 | 11 | |
| 10 | 1999 | 108 | |
| 11 | 1997 | 17 | |
| 12 | 1995 | 67 | |
| 13 | 1992 | 29 | |
| 14 | 1992 | 21 | |
| 15 | 1991 | 7 | |
| 16 | 1990 | 5 | |
| 17 | 1989 | 26 | |
| 18 | 1979 | 14 | |
| 19 | Immune response in fulminant viral hepatitis, type B. | 1976 | 9 |
| 20 | 1976 | 40 |
About Edward Tabor
Edward Tabor is a scholar working on Hepatology, Epidemiology, Oncology, Pharmacology and Infectious Diseases, having authored 146 papers that have together received 4.3k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (87 papers), Hepatitis C virus research (50 papers), Liver Disease Diagnosis and Treatment (34 papers), Hepatitis Viruses Studies and Epidemiology (33 papers), Cancer-related Molecular Pathways (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Immunotherapy and Immune Responses (8 papers) and Animal Virus Infections Studies (7 papers). The work is most often cited by research in Hepatology (2.5k citations), Epidemiology (2.7k citations), Infectious Diseases (637 citations), Animal Science and Zoology (190 citations) and Virology (88 citations). Edward Tabor has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Robert J. Gerety, Chu Chieh Hsia, R. J. Gerety, Robert H. Purcell, Richard E. Sampliner, L. A. Smallwood, Yutaka Nakashima, Milton April, Jay S. Epstein and Lewellys F. Barker. Their work appears in journals such as Journal of Medical Virology, Transfusion, The Journal of Infectious Diseases, The Lancet and Journal of Viral Hepatitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.